Tag: androgel

$140 Million Awarded in AndroGel Testosterone Trial

$140 Million Awarded in AndroGel Testosterone Trial

A jury in Illinois has found AbbVie Inc. responsible for failing to warn about the heart attack risks of the "Low T" testosterone gel AndroGel.

/ October 6, 2017

Ex-FDA Chief Claims AbbVie Promoted AndroGel for ‘Off-Label’ Uses

David Kessler, Commissioner of the U.S. Food and Drug Administration (FDA) from 1990 to 1997, told jurors Tuesday that he believes AbbVie Inc. illegally promoted the testosterone supplement Androgel for use in aging men without adequately testing safety of the...

/ June 9, 2017
Testosterone Blood Clot Lawsuit

Testosterone Ups Blood Clot Risk by 63% In First 6 Months

Men who start testosterone therapy are 63% more likely to have a Venous Thromboembolism (VTE) in the first 6 months of treatment, with the risk peaking at 3 months. Over 6,300 lawsuits have been filed by men who were injured...

/ December 23, 2016